Abstract
The metabolism and pharmacokinetics of a synthetic antibacterial phosphonodipeptide, alafosfalin, have been studied in rats, baboons, and human volunteers. The compound was rapidly absorbed from the injection site after subcutaneous and intramuscular administration and gave peak plasma concentrations at 15 to 20 min after dosing. Distribution studies showed that high drug concentrations were produced in inflammatory exudates and most tissues except brain. Alafosfalin was rapidly cleared from the general circulation, mainly by the kidney. Plasma half-lives were 20 min in rats and approximately 1 h in baboons and humans. Alafosfalin was well absorbed after oral administration, but was extensively hydrolyzed to alanine and L-1-aminoethylphosphonic acid before it reached the general circulation. This first-pass metabolism was less marked in humans than in animals. Administration of 200-mg intramuscular and 500-mg oral doses produced concentrations of intact phosphonodipeptide in human plasma and urine which were in excess of the in vitro minimal inhibitory concentrations for many pathogenic organisms. The rate of absorption and elimination of alafosfalin in humans were also very similar to published data on beta-lactam antibiotics. This suggests that the pharmacokinetics can be matched to provide synergistic combinations for clinical use.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen J. G., Atherton F. R., Hall M. J., Hassall C. H., Holmes S. W., Lambert R. W., Nisbet L. J., Ringrose P. S. Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides. Antimicrob Agents Chemother. 1979 May;15(5):684–695. doi: 10.1128/aac.15.5.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Atherton F. R., Hall M. J., Hassall C. H., Lambert R. W., Lloyd W. J., Ringrose P. S. Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob Agents Chemother. 1979 May;15(5):696–705. doi: 10.1128/aac.15.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Atherton F. R., Hall M. J., Hassall C. H., Lambert R. W., Ringrose P. S. Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships. Antimicrob Agents Chemother. 1979 May;15(5):677–683. doi: 10.1128/aac.15.5.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chow M. S., Ronfeld R. A. Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics. J Clin Pharmacol. 1975 May-Jun;15(5-6):405–418. doi: 10.1002/j.1552-4604.1975.tb02362.x. [DOI] [PubMed] [Google Scholar]
- Matthews D. M. Introduction. Membrane transport of peptides. Ciba Found Symp. 1977;(50):5–14. [PubMed] [Google Scholar]
- doi: 10.1177/00359157770700S903. [DOI] [PMC free article] [Google Scholar]
- Radhakrishnan A. N. Intestinal dipeptidases and the dipeptide transport in the monkey and in man. Ciba Found Symp. 1977;(50):37–59. doi: 10.1002/9780470720318.ch4. [DOI] [PubMed] [Google Scholar]
- Silk D. B. Amino acid and peptide absorption in man. Ciba Found Symp. 1977;(50):15–29. doi: 10.1002/9780470720318.ch3. [DOI] [PubMed] [Google Scholar]